Search research articles
Contact Us
Filters
Showing results (1401-1410 of 1,501) with videos related to
Page
of 151
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2011
Aberrant AKT activation drives well-differentiated liposarcoma
Alejandro Gutierrez, Eric L Snyder, Adrian Marino-Enriquez, et al.
Pediatric Obesity
|
February 1, 2019
Associations of sleep patterns with metabolic syndrome indices, body composition, and energy intake in children and adolescents
Sarah J Mi, Nichole R Kelly, Robert J Brychta, et al.
The New England Journal of Medicine
|
April 4, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumors
Michelle A Maynard, Adrian Marino-Enriquez, Jonathan A Fletcher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2019
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
Edeltraud J Lenk, Henri C Moungui, Michel Boussinesq, et al.
Oncotarget
|
June 6, 2014
Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
Chun-Nan Yeh, Chueh-Chuan Yen, Yen-Yang Chen, et al.
British Journal of Cancer
|
February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
César Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure
George D Demetri, Michael C Heinrich, Jonathan A Fletcher, et al.
Molecular Cancer Therapeutics
|
July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy
Thomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cell Metabolism
|
March 6, 2024
Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability
Stanislaw Deja, Justin A Fletcher, Chai-Wan Kim, et al.
Page
of 151
Search research articles
Search
Showing results (1401-1410 of 1,501) with videos related to
Sort By:
Page
of 151
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
E Ben-Ami, C M Barysauskas, M von Mehren, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2011
Aberrant AKT activation drives well-differentiated liposarcoma
Alejandro Gutierrez, Eric L Snyder, Adrian Marino-Enriquez, et al.
Pediatric Obesity
|
February 1, 2019
Associations of sleep patterns with metabolic syndrome indices, body composition, and energy intake in children and adolescents
Sarah J Mi, Nichole R Kelly, Robert J Brychta, et al.
The New England Journal of Medicine
|
April 4, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumors
Michelle A Maynard, Adrian Marino-Enriquez, Jonathan A Fletcher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2019
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
Edeltraud J Lenk, Henri C Moungui, Michel Boussinesq, et al.
Oncotarget
|
June 6, 2014
Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
Chun-Nan Yeh, Chueh-Chuan Yen, Yen-Yang Chen, et al.
British Journal of Cancer
|
February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
César Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure
George D Demetri, Michael C Heinrich, Jonathan A Fletcher, et al.
Molecular Cancer Therapeutics
|
July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy
Thomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cell Metabolism
|
March 6, 2024
Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability
Stanislaw Deja, Justin A Fletcher, Chai-Wan Kim, et al.
Page
of 151